We verified the induction and tumor-suppressive functions of a top predicted lncRNA in lung adenocarcinoma (LUAD) cells upon p53 activation and its downregulation in our LUAD patient cohort that correlates with poor overall survival across cancer types. The gene discussed is TP53; the disease is cancer.